community download

"Minimising the immunogenicity of biopharmaceuticals: current status of monitoring immunogenicity across the R&D value chain"

information we require

please check before submitting



Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

 

Sylvia Julien, principal scientist, senior project leader global scientific affairs and strategic sourcing, Ipsen, explores in her presentation:

  • Immunogenicity and influencing factors
  • Immunogenicity risk assessment, stage-based
  • Conclusion and perspectives